Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04728620 · ClinicalTrials.gov registry record · NA

Evaluation of a Patient Portal Intervention to Address Diabetes Care Gaps

A NA study of Diabetes Mellitus, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT04728620 is a NA study of Diabetes Mellitus that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 60 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04728620, a NA study of Diabetes Mellitus, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the usability of a novel patient portal intervention designed to: (a) notify patients when selected, clinically meaningful, evidence-based diabetes monitoring \& preventative care (e.g., annual diabetes eye exam) become due and (b) allow patients to initiate orders for the care. In addition, the investigators will assess pre-post change on secondary psychosocial outcomes (e.g., self-efficacy).

Conditions Studied

Interventions

  • OTHER Diabetes Care Gaps Patient Portal Intervention

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2021-05-06
Est. Completion 2022-05-25
Phase NA

What the Registry Record Tells You About NCT04728620

The ClinicalTrials.gov registry entry for NCT04728620 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Diabetes Care Gaps Patient Portal Intervention is the first listed.

NCT04728620 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT04728620 about?

NCT04728620 is a clinical study titled "Evaluation of a Patient Portal Intervention to Address Diabetes Care Gaps". The purpose of this study is to evaluate the usability of a novel patient portal intervention designed to: (a) notify patients when selected, clinically meaningful, evidence-based diabetes monitoring \& preventative care (e.g., annual diabetes eye exam) become due and (b) allow patients to initiate ...

What is the current status of trial NCT04728620?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2021-05-06. Estimated completion is 2022-05-25.

What conditions does trial NCT04728620 study?

This clinical trial studies the following conditions: Diabetes Mellitus.

What interventions are being tested in trial NCT04728620?

The interventions under investigation include: Diabetes Care Gaps Patient Portal Intervention (OTHER).

Who is sponsoring clinical trial NCT04728620?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04728620 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.